Cell Therapy for Liver Disease
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
102
NCT05035108
The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy
Phase: Early Phase 1
Role: Collaborator
Start: Sep 5, 2021
Completion: Nov 30, 2030
NCT05989958
The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 22, 2023
Completion: Sep 30, 2026
Loading map...